Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1650 (LINC01650) is a noncoding RNA gene found in humans, classified as a lincRNA. LincRNAs are autonomously transcribed noncoding RNAs longer than 200 nucleotides that do not overlap protein-coding genes. These RNAs are part of the broader family of long non-coding RNAs (lncRNAs), and function primarily in epigenetic regulation, gene expression modulation, and chromatin architecture, often exhibiting tissue specificity. The specific biological function and clinical role for LINC01650 remains uncharacterized in the literature. No direct evidence links LINC01650 to disease, drug interaction, or use as a biomarker. Currently, LINC01650 is mainly documented as a noncoding RNA locus without known clinical or pharmacological utility.
None — There are no drug mechanisms of action described for this specific RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1650 (LINC01650).